Tredegar Corporation 2007 Annual Report (10-K) Summary
Business Context and Reporting Period
This report covers the fiscal year ended December 31, 2007. Tredegar Corporation operates through two primary segments: Film Products (plastic films, elastics, and laminates for personal care and packaging) and Aluminum Extrusions (soft-alloy aluminum extrusions for construction and industrial markets). The company is headquartered in Richmond, Virginia, and employs approximately 2,600 people in continuing operations. A significant strategic shift occurred with the sale of its Canadian aluminum extrusions business in February 2008, which is reported as discontinued operations.
Key Financial Metrics
| Metric | 2007 | 2006 |
|---|---|---|
| Total Sales | $922.6 million | $937.6 million |
| Income from Continuing Operations | $34.9 million | $35.3 million |
| Net Income (Loss) | $15.2 million | $38.2 million |
| Diluted EPS (Continuing Ops) | $0.90 | $0.91 |
| Diluted EPS (Net Income) | $0.39 | $0.98 |
| Cash Flow from Operations | $95.6 million | $104.6 million |
| Total Debt | $82.1 million | $62.5 million |
| Cash and Equivalents | $48.2 million | $40.9 million |
| Shareholders' Equity | $491.3 million | $516.6 million |
Material Changes vs. Prior Period
- Revenue Decline: Consolidated sales decreased 1.6% to $922.6 million, driven primarily by a 7.9% drop in Aluminum Extrusions sales due to lower volume in construction markets. Conversely, Film Products sales increased 3.9%.
- Discontinued Operations Impact: Net income was significantly reduced by a $19.7 million loss from discontinued operations, primarily related to the impairment of assets in the Canadian aluminum extrusions business sold in early 2008.
- Segment Performance:
- Film Products: Operating profit from ongoing operations rose 3.1% to $59.4 million, aided by currency appreciation and higher value product mix, despite a volume decline.
- Aluminum Extrusions: Operating profit from ongoing U.S. operations fell 9.8% to $16.5 million due to a 15.9% volume decrease.
- Share Repurchases: The company repurchased approximately 4.8 million shares in 2007 at an average price of $16.00, reducing outstanding shares significantly.
- Tax Rate: The effective tax rate on continuing operations increased to 41.1% from 35.9%, largely due to valuation allowances on capital loss carry-forwards.
Guidance, Outlook, and Risks
- Outlook: Management expects capital expenditures to increase in 2008, particularly a $24 million expansion at the Carthage, Tennessee aluminum plant. Net pension income is projected to be $5.5 million in 2008.
- Customer Concentration: The company faces significant risk from its reliance on The Procter & Gamble Company (P&G), which accounted for approximately 29% of consolidated net sales in 2007.
- Raw Material Volatility: Profitability is sensitive to the costs of resin (Film Products) and aluminum/energy (Aluminum Extrusions). While pass-through mechanisms exist, there is no assurance costs can be fully offset.
- Investments: The company holds high-risk investments, including a $10 million stake in Harbinger Capital Partners and a $6.5 million investment in a drug delivery company, which are subject to market volatility and development risks.
- Debt Covenants: The company maintains a $300 million revolving credit facility. Non-compliance with covenants could result in all debt becoming due, though the company reported compliance as of year-end.
Investor Verification Checklist
- Discontinued Operations: Verify the final purchase price and working capital adjustments for the Canadian aluminum business sale completed in February 2008.
- P&G Dependency: Monitor sales trends to P&G, as a reduction in this relationship would have a material adverse effect.
- Raw Material Pass-Through: Assess the company's ability to pass through rising resin and aluminum costs to customers in 2008.
- Investment Valuation: Review the fair value of the Harbinger and drug delivery investments, noting the lack of secondary markets and speculative nature.
- Tax Position: Confirm the resolution of the IRS examination regarding the captive insurance subsidiary, with a potential settlement cost of $1.4 million.